China Pharmaceutical Contract Manufacturing And Research Services Market Size & Outlook
Related Markets
China pharmaceutical contract manufacturing and research services market highlights
- The China pharmaceutical contract manufacturing and research services market generated a revenue of USD 27,133.5 million in 2023 and is expected to reach USD 46,481.0 million by 2030.
- The China market is expected to grow at a CAGR of 8% from 2024 to 2030.
- In terms of segment, manufacturing was the largest revenue generating service in 2023.
- Research is the most lucrative service segment registering the fastest growth during the forecast period.
Pharmaceutical contract manufacturing and research services market data book summary
| Market revenue in 2023 | USD 27,133.5 million |
| Market revenue in 2030 | USD 46,481.0 million |
| Growth rate | 8% (CAGR from 2023 to 2030) |
| Largest segment | Manufacturing |
| Fastest growing segment | Research |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Manufacturing, Research |
| Key market players worldwide | Catalent Inc, Pharmaceutical Product Development, AbbVie Inc, Baxter International Inc, Grifols SA Ordinary Shares - Class A, Dalton Pharma Services, Boehringer Ingelheim, Lonza Group Ltd |
Other key industry trends
- In terms of revenue, China accounted for 11.1% of the global pharmaceutical contract manufacturing and research services market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China pharmaceutical contract manufacturing and research services market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 34,847.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Contract Manufacturing And Research Services Market Scope
Pharmaceutical Contract Manufacturing And Research Services Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Dalton Pharma Services | View profile | 51-100 | Toronto, Ontario, Canada, North America | https://www.dalton.com/ |
| Pharmaceutical Product Development | View profile | 10001+ | Wilmington, North Carolina, United States, North America | https://ppd.com |
| Grifols SA Ordinary Shares - Class A | View profile | 23737 | Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, Spain, 08174 | https://www.grifols.com |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
China pharmaceutical contract manufacturing and research services market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical contract manufacturing and research services market will help companies and investors design strategic landscapes.
Manufacturing was the largest segment with a revenue share of 66.27% in 2024. Horizon Databook has segmented the China pharmaceutical contract manufacturing and research services market based on manufacturing, research covering the revenue growth of each sub-segment from 2018 to 2030.
China is considered to be the second-largest pharmaceutical market in the world. High demand for generics in the country and a large patient population are factors driving the demand for drugs in the country.
Innovative therapies are also in demand in the country due to the wide patient pool. All such factors are expected to drive the demand for contract manufacturing and drug development services in China.
Reasons to subscribe to China pharmaceutical contract manufacturing and research services market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China pharmaceutical contract manufacturing and research services market databook
-
Our clientele includes a mix of pharmaceutical contract manufacturing and research services market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China pharmaceutical contract manufacturing and research services market, including forecasts for subscribers. This country databook contains high-level insights into China pharmaceutical contract manufacturing and research services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China Finished Dose Formulations - Pharmaceutical Contract Manufacturing Market, 2024 - 2030 (US$M)
China Pharmaceutical Contract Manufacturing And Research Services Market Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
